The brightest minds in the CDMO industry.
From early development through to commercial manufacturing.
Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)
We proudly introduce a new addition to the Recipharm family
The combination of Recipharm and Bespak – a leading player in the manufacture of innovative drug delivery devices – is highly complementary as both companies provide different products and services within the same value chain for a number of customers.
Celebrating 25 years
Recipharm has had an incredible journey since it was formed in 1995, and is now a leading global player in the CDMO industry. This year we celebrate our successful journey over 25 years.
Founders Thomas Eldered and Lars Backsell:
"Recipharm has not been a two man-show, as there are a lot of people that have contributed over the years, and we’ve been fortunate enough to recruit and retain excellent people."
Whether you’re a large or small pharmaceutical company, our talented team can develop and transform your promising molecule into a product. We’ve supported many clients over the years, and you can be next.
Torkel Gren - General Manager
“Recipharm takes responsibility for the full phase I programme, from formulation to clinical trial implementation with patients.”
With production facilities across the world covering a range of product types and dosage forms, you can count on our manufacturing expertise to reliably deliver your product on time, every time. Shall we get started?
Ann Flodin - General Manager
"We are focused on managing complexity for our customers, this means providing a full service offering to simplify the supply chain."